- Report
- November 2023
- 157 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2023
- 154 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2023
- 161 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2023
- 151 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2023
- 152 Pages
United States
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2023
- 171 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- October 2023
- 162 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- October 2023
- 164 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- September 2023
- 159 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- June 2023
- 138 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- March 2023
- 161 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- September 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- September 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- March 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- March 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- January 2022
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- November 2021
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP
- Report
- July 2021
- 120 Pages
Global
From €2227EUR$2,500USD£1,932GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more